Neurosense Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Neurosense Therapeutics (NRSN) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Neurosense Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Neurosense Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurosense Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $151k | 80k | 1.89 |
| 2024-12-31 | $123k | 103k | 1.20 |
| 2024-06-30 | $1.7k | 1.5k | 1.12 |
| 2024-03-31 | $2.7k | 1.5k | 1.82 |
| 2023-12-31 | $1.2k | 1.5k | 0.79 |
| 2022-12-31 | $5 | 4 | 1.25 |